BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 31422358)

  • 1. Sudden cardiac death in families with premature cardiovascular disease.
    Bruikman C; de Ronde MWJ; Amin A; Levy S; Lof P; de Ruijter U; Hovingh K; Tan HL; Pinto-Sietsma SJ
    Heart; 2020 Feb; 106(3):228-232. PubMed ID: 31422358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Yield and Pitfalls of Ajmaline Testing in the Evaluation of Unexplained Cardiac Arrest and Sudden Unexplained Death: Single-Center Experience With 482 Families.
    Tadros R; Nannenberg EA; Lieve KV; Škorić-Milosavljević D; Lahrouchi N; Lekanne Deprez RH; Vendrik J; Reckman YJ; Postema PG; Amin AS; Bezzina CR; Wilde AAM; Tan HL
    JACC Clin Electrophysiol; 2017 Dec; 3(12):1400-1408. PubMed ID: 29759671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual phenotypic transmission in Brugada syndrome.
    Hermida JS; Arnalsteen-Dassonvalle E; Kubala M; Mathiron A; Traulle S; Anbazhagan K; Hermida A; Rochette J
    Arch Cardiovasc Dis; 2013; 106(6-7):366-72. PubMed ID: 23810369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A balanced translocation disrupting SCN5A in a family with Brugada syndrome and sudden cardiac death.
    Yeates L; Ingles J; Gray B; Singarayar S; Sy RW; Semsarian C; Bagnall RD
    Heart Rhythm; 2019 Feb; 16(2):231-238. PubMed ID: 30170230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brugada syndrome and abnormal splicing of SCN5A in myotonic dystrophy type 1.
    Wahbi K; Algalarrondo V; Bécane HM; Fressart V; Beldjord C; Azibi K; Lazarus A; Berber N; Radvanyi-Hoffman H; Stojkovic T; Béhin A; Laforêt P; Eymard B; Hatem S; Duboc D
    Arch Cardiovasc Dis; 2013 Dec; 106(12):635-43. PubMed ID: 24140416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myotonic dystrophy type 1 mimics and exacerbates Brugada phenotype induced by Nav1.5 sodium channel loss-of-function mutation.
    Pambrun T; Mercier A; Chatelier A; Patri S; Schott JJ; Le Scouarnec S; Chahine M; Degand B; Bois P
    Heart Rhythm; 2014 Aug; 11(8):1393-400. PubMed ID: 24768612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic ajmaline challenge in patients with long QT 3 syndrome caused by the most common mutation: a multicentre study.
    Hohmann S; Rudic B; Konrad T; Duncker D; König T; Tülümen E; Rostock T; Borggrefe M; Veltmann C
    Europace; 2017 Oct; 19(10):1723-1729. PubMed ID: 27915266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac evaluation of pediatric relatives in sudden arrhythmic death syndrome: a 2-center experience.
    Wong LC; Roses-Noguer F; Till JA; Behr ER
    Circ Arrhythm Electrophysiol; 2014 Oct; 7(5):800-6. PubMed ID: 25194972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel
    Monasky MM; Micaglio E; Ciconte G; Rivolta I; Borrelli V; Ghiroldi A; D'Imperio S; Binda A; Melgari D; Benedetti S; Mitrovic P; Anastasia L; Mecarocci V; Ćalović Ž; Casari G; Pappone C
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a SCN5A founder mutation causing sudden death, Brugada syndrome, and conduction blocks in Southern Italy.
    Curcio A; Malovini A; Mazzanti A; Memmi M; Gambelli P; La Rosa F; Bloise R; Indolfi C; Bellazzi R; Napolitano C
    Heart Rhythm; 2021 Oct; 18(10):1698-1706. PubMed ID: 34245912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unique clinical characteristics and SCN5A mutations in patients with Brugada syndrome in Taiwan.
    Juang JM; Tsai CT; Lin LY; Liu YB; Yu CC; Hwang JJ; Chen JJ; Chiu FC; Chen WJ; Tseng CD; Chiang FT; Yeh HM; Sherri Yeh SF; Lai LP; Lin JL
    J Formos Med Assoc; 2015 Jul; 114(7):620-6. PubMed ID: 26154754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender difference in clinical and genetic characteristics of Brugada syndrome: SADS-TW BrS registry.
    Chen CJ; Juang JJ; Lin LY; Liu YB; Ho LT; Yu CC; Huang HC; Lin TT; Liao MC; Chen JJ; Hwang JJ; Chen WJ; Yeh SS; Yang DH; Chiang FT; Lin JL; Lai LP; Horie M;
    QJM; 2019 May; 112(5):343-350. PubMed ID: 30690642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotype-phenotype relationship and risk stratification in loss-of-function SCN5A mutation carriers.
    Robyns T; Nuyens D; Vandenberk B; Kuiperi C; Corveleyn A; Breckpot J; Garweg C; Ector J; Willems R
    Ann Noninvasive Electrocardiol; 2018 Sep; 23(5):e12548. PubMed ID: 29709101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low rate of cardiac events in first-degree relatives of diagnosis-negative young sudden unexplained death syndrome victims during follow-up.
    van der Werf C; Stiekema L; Tan HL; Hofman N; Alders M; van der Wal AC; van Langen IM; Wilde AA
    Heart Rhythm; 2014 Oct; 11(10):1728-32. PubMed ID: 24882506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant response to ajmaline challenge in SCN5A mutation carriers: experience from a large familial study.
    Gandjbakhch E; Fressart V; Duthoit G; Marquié C; Deharo JC; Pousset F; Hebert JL; Simon F; Himbert C; Klug D; Charron P; Hidden-Lucet F
    Int J Cardiol; 2014 Mar; 172(1):256-8. PubMed ID: 24476701
    [No Abstract]   [Full Text] [Related]  

  • 16. Value of the sodium-channel blocker challenge in Brugada syndrome.
    Therasse D; Sacher F; Babuty D; Mabo P; Mansourati J; Kyndt F; Redon R; Schott JJ; Barc J; Probst V; Gourraud JB
    Int J Cardiol; 2017 Oct; 245():178-180. PubMed ID: 28784436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Diagnostic Yield of Brugada Syndrome After Sudden Death With Normal Autopsy.
    Papadakis M; Papatheodorou E; Mellor G; Raju H; Bastiaenen R; Wijeyeratne Y; Wasim S; Ensam B; Finocchiaro G; Gray B; Malhotra A; D'Silva A; Edwards N; Cole D; Attard V; Batchvarov VN; Tome-Esteban M; Homfray T; Sheppard MN; Sharma S; Behr ER
    J Am Coll Cardiol; 2018 Mar; 71(11):1204-1214. PubMed ID: 29544603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for cardiac events in patients with Brugada syndrome: A PRISMA-compliant meta-analysis and systematic review.
    Wu W; Tian L; Ke J; Sun Y; Wu R; Zhu J; Ke Q
    Medicine (Baltimore); 2016 Jul; 95(30):e4214. PubMed ID: 27472692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial cardiological and targeted genetic evaluation: low yield in sudden unexplained death and high yield in unexplained cardiac arrest syndromes.
    Kumar S; Peters S; Thompson T; Morgan N; Maccicoca I; Trainer A; Zentner D; Kalman JM; Winship I; Vohra JK
    Heart Rhythm; 2013 Nov; 10(11):1653-60. PubMed ID: 23973953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p.Y1449C SCN5A mutation associated with overlap disorder comprising conduction disease, Brugada syndrome, and atrial flutter.
    Hothi SS; Ara F; Timperley J
    J Cardiovasc Electrophysiol; 2015 Jan; 26(1):93-7. PubMed ID: 24903439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.